[0001] This invention relates to the synthesis of oxanosine, an antibiotic having carcinostatic
activity.
[0002] Oxanosine (5-amino-3-(3-D-ribofuranosyl-3H-imidaso[4,5-d][1,3]oxazin-7-one) was isolated
by Hamao Umezawa et al from culture broth of Streptomyces capreolus MG265-CF3 (Deposit
No. 5735 at the Fermentation Research Institute, Agency of Industrial Science and
Technology, Ministry of International Trade and Industry of Japan) (see the Journal
of Antibiotics, Vol. 34, p. 1216-1218, 1981).
[0003] We, the inventors of this invention, made extensive studies on how to synthesize
oxanosine, and found out that oxanosine expressed by the formula (II)

can be synthesized in the manner described below. A 5-amino-1-(o-protected-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid alkyl ester of the general formula (III)

wherein R
1 represents a protective group; R
2 and R
3 each represent hydrogen or a protective group, or R
1 and R
2 may be bound together to form a ring, and R
4 represents lower alkyl is condensed with a carbonyl isothiocyanate of the general
formula (IV)

wherein X represents a lower alkoxy group or a phenyl group, to form a 5-substituted
amino-1-(o-protected-β-D-ribofuranosyl)-4-imidazolecarboxylic acid alkyl ester of
the general formula (V)

wherein R
1, R
2, R
3, R
4 and X are as defined above.
[0004] The resulting compound is subjected to the action of an alkyl iodide to form an s-alkyl
derivative of the general formula (VI)

wherein R
1, R
2, R
3, R
4 and X are as defined above, and R
5 represents a lower alkyl group.
[0005] This compound is heated in the presence of an alkali metal hydroxide such as sodium
hydroxide or potassium hydroxide, or an alkali metal carbonate such as sodium carbonate
or potassium carbonate) to form a 5-cyanamide-1-(o-protected-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid metal salt of the formula (VII)

wherein M represents an alkali metal atom.
[0006] Neutralization of the compound of the formula (VII) gives a 2'-o-protected oxanosine
of the general - formula (1):

wherein R
1, R
2 and R
3 are as defined above.
[0007] The oxanosine of the formula (II) is obtained by hydrolyzing the 2'-O-protected oxanosine
of the formula (I) above, thereby eliminating the protective group(s).
[0008] The compound of the general formula (III), in which R
4 represents an ethyl group, R
3 is a hydrogen atom, and R
1 and R
2 are bonded together to form an isopropylidene group, i.e., 5-amino-1-(2,3-o-isopropylidene-α-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester, is a known compound synthesized by N. J. Cusack et al (Journal of
Chemical Society, Part I, 1973 Issue, p. 1720, 1973). Other compounds expressed by
the general formula (III) can be synthesized in accordance with the method described
in this literature. Examples of the lower alkyl group in the present invention are
methyl, ethyl, propyl and butyl.
[0009] Examples of the carbonyl isothiocyanate of the general formula (IV) include methoxycarbonyl
isothiocyanate, ethoxycarbonyl isothiocyanate, propoxycarbonyl isothiocyanate and
benzoyl isothiocyanate. In the case of benzoyl isothiocyanate, a substituent which
will exert no adverse influence on the reaction may be present on the phenyl group.
[0010] The condensation between the compound of the formula (III) and the compound of the
formula (IV) can be carried out, at a temperature of 0 to 40°C, preferably, room temperature,
usually, in an organic solvent, e.g., a polar organic solvent such as dimethylformamide.
[0011] R
1 in the general formula (I) of this invention may be any protective group which can
be used to protect a hydroxyl group. Examples include a tetrahydropyranyl group, a
4-methoxytetrahydropyran-4-yl group, a tetrahydrothiofuranyl group and a tetrahydrothiopyranyl
group. Preferred examples of R
1 are those bound to R
2 to form a ring, which serves as a ketal-type protective group. Examples of the protective
group resulting from ring formation are substituted or unsubstituted alkylidene groups,
such as an isopropylidene group, a p-anisylidene group, a benzylidene group, a cyclohexylidene
group, an ethylidene group and a methoxyethylidene group.
[0012] The above-mentioned elimination of the protective group(s) by hydrolysis can be performed
by a customary method. If the protective group is a tetrahydropyranyl group or one
of a ketal type, such as an isopropylidene group, for example, it is preferred to
eliminate it with heating (say, at a temperature of 40°C or higher, preferably, under
reflux) in the presence of an acid such as hydrochloric acid or acetic acid.
[0013] The present invention will be described in more detail by reference to the following
examples.
Example 1
Conversion of 2',3'-O-isopropylideneoxanosine into oxanosine
[0014] 10.0 mg of 2',3'-O-isopropylideneoxanosine was dissolved in 1 ml of a 10% aqueous
solution of acetic acid, and the resulting solution was refluxed for 1.5 hours. The
solution was diluted with 15 ml of water, and the dilution was adsorbed onto 1 ml
of activated carbon. The adsorbate was eluted with a 70% aqueous solution of acetone.
The eluate was concentrated under reduced pressure to remove acetone. The residual
aqueous solution gave 7.2 mg of oxanosine as colorless platey crystals. The yield
was 84.4%, and the decomposition point, 197-199°C.
[0015] The 2',3'-O-isopropylidene-oxanosine can be obtained by the following reaction steps:
(a) Synthesis of 5-(N'-ethoxycarbonylthiocarbamoyl)amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester.
[0016] The 76.0 mg of 5-amino-1-(2,3-0-isopropylidene-j3-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester was dissolved in 1 ml of dimethylformamide. To the solution was added
0.02 ml of ethoxycarbonyl isothiocyanate, and the mixture was stirred at room temperature
for 16 hours. Then, the mixture was concentrated to dryness, and the residue was dissolved
in a small amount of ethyl alcohol. The solution was purified by preparative thin-layer
chromatography on silica gel using benzene-ethyl alcohol (10: 1) as a solvent system.
The 84.8 mg of 5-(N'-ethoxycarbonylthiocarbamoyl)amino-1-(2.3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester was obtained as a lyophilized powder.
Yield:-81.9%
m.p.: 95.5―99.0°C (in a sealed tube) Specific rotation:

= -47.7° (c = 1, CHCI3)
Molecular formula: C18H26N4O8S
Molecular weight: 458.50
UV spectrum:

nm (log e):
289 (4.24), 248 (4.62), 212 (4.67)
IR spectrum:

: 1710 cm-1
NMR spectrum for proton (chloroform-d):
8.00 ppm (s, 1H), 5.9 (d, 1H), 4.96 (d, 2H), 4.30 (m, 5H), 3.80 (m, 2H), 1.50 (s,
H), 1.30 (m, 9H),
[0017] (b) Synthesis of 5-(N'-ethoxycarbonyl-S-methylisothiocarbamoyl)amino-1-(2,3-0-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester
[0018] The 8.48 mg of 5-(N'-ethoxycarbonylthiocarbamoyl)amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester was dissolved in 1.85 ml of an aqueous solution of 0.1 N sodium hydroxide.
To the solution was added 0.013 ml of methyl iodide, followed by stirring the mixture
for 16 hours at room temperature. Then, the mixture was diluted with 30 ml of water,
and the dilution was adsorbed onto 5 ml of activated carbon. The adsorbate was eluted
with a 70% aqueous solution of acetone. The eluate gave 46.9 mg of 5-(N'-ethoxycarbonyl-S-methylisothiocarbamoyl)amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester as a glassy substance.
Yield: 55.0%
m.p.: 64.5―67.5°C
Specific rotation:

= -26.0° c = 1, CHCl3)
Molecular formula: C19H28N4O8S
Molecular weight: 472.52
UV spectrum: λMeOHmax nm (log s):
267 (4.27), 253 (4.26), 212 (4.41)
IR spectrum: νc=oKBr: 1750 cm-1
NMR spectrum for proton (chloroform-d):
7.85 (s, 1H), 5.70 (d, 1H), 4.95 (d, 2H), 4.20 (m, 5H), 3.85 (m, 2H), 2.46 (s, 3H),
1.55 (s, 3H), 1.25 (m, 9H).
[0019] (c) Synthesis of 2',3'-O-isopropylideneoxanosine
[0020] The 42.3 mg of 5-(N'-ethoxycarbonyl-S-methylisothiocarbamoyl)amino-1-(2,3-0-isopropylidene-[3-D-ribofuranosyl)-4-imidazole
carboxylic acid ethyl ester was dissolved in 2.5 ml of an aqueous solution of 0.2N
sodium hydroxide. The solution was refluxed for 30 minutes, and immediately thereafter,
it was lyophilized to obtain a powder. The IR spectrum of the powder showed an absorption
band for nitrile at 2140 cm-
1, which confirmed the formation of the disodium salt of 5-cyanamido-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid. This powder was dissolved in 0.1 N hydrochloric acid for neutralization, and
adsorbed onto 20 ml of activated carbon. The adsorbate was eluted with a 70% aqueous
solution of acetone, and the eluate was concentrated to dryness. The residue was dissolved
in a small amount of ethyl alcohol, and the solution was purified by preparative thin-layer
chromatography on silica gel using ethyl acetate-methyl alcohol (9:1) as a solvent
system. Crystallization from hot water gave 5.5 mg of 2',3'-O-isopropylideneoxanosine
as colorless needles.
Yield: 18.5%
m.p.: 166.0-167.50C
Mixed m.p. of this product and the authentic substance obtained from oxanosine: 166:0-167.5°C
Specific rotation:

= -34° (c = 0.5, MeOH)
Molecular formula: C13H16N4O6
Molecular weight: 324.30
UV spectrum: λMeOHmax nm (log e):
285 (4.03), 246 (4.19), 207 (4.28).
IR spectrum: νc=oKBr: 1770 cm-1
NMR spectrum for proton (methanol-d4):
7.96 ppm (s, 1H), 5.97 (d, 1H), 5.18 (d, d, 1H), 5.00 (d, d, 1H), 4.30 (m, 1H), 3.70
(d, 2H), 1.55 (s, 3H), 1.37 (s, 3H).
[0021] A further method for the preparation of 2',3'-O-isopropylideneoxanosine comprises
the following steps:
(d) Synthesis of 5-(N'-benzoylthiocarbamoyl)amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyll-4-imidazolecarboxylic
acid ethyl ester
[0022] The 30.7 mg of 5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester was dissolved in 1 ml of dimethyl sulfoxide. A 0.3 ml of benzoyl
isothiocyanate was added to the solution, and the mixture was reacted for 16 hours
at room temperature. The reaction mixture was concentrated under reduced pressure,
and the oily residue was dissolved in a small amount of ethyl alcohol. The solution
was purified by preparative thin-layer chromatography using benzene-ethyl alcohol
(10:1) as a solvent system. The purified material gave 31.2 mg of 5-(N'-benzoylthiocarbamoyl)amino-1-(2,3-O-isopropylidene-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester as an amorphous powder.
Yield: 67.8%.
[0023] (e) Synthesis of 5-(N'-benzoyl-S-methylisothiocarbamoyl)amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester
[0024] The 30.0 mg of 5-(N'-benzoylthiocarbamoyl)amino-1-(2,3-O-iso-propylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester was dissolved in 0.6 ml of an. aqueous solution of 0.1N sodium hydroxide.
A 0.01 ml of methyl iodide was added to the solution, and the mixture was stirred
for 3 hours at room temperature. Crystals formed were collected by filtration, washed
with water, and dried to obtain 22.3. mg of 5-(N'-benzoyl-S-methylisothiocartramoyl)amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-4-imidazolecarboxylic
acid ethyl ester in 72.3% yield.
[0025] (f) The resulting product was cyclized in accordance with the procedure of step (c)
to obtain 2',3'-0-isopropylideneoxanosine.